Wednesday, November 4, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

This MIT Scientist Injected SS31 Peptide for 20 Years. Now It's FDA Approved and Targeting Mitochondria in Ways No Drug Ever Has

Peptides are exploding in popularity, and Harvard geneticist David Sinclair says he has never seen anything like

DO
By Daniel Okafor · Regulatory Correspondent
Nov 4 10:00 ETSource: BoxLife Magazine

From the source

This MIT Scientist Injected SS31 Peptide for 20 Years. Now It's FDA Approved and Targeting Mitochondria in Ways No Drug Ever Has

Peptides are exploding in popularity, and Harvard geneticist David Sinclair says he has never seen anything like it.

Read at boxlifemagazine.com
PeptiPrescribed peptides from $99/moSee all →